Literature DB >> 15610258

Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy.

Yasuo Ishii1, Tokihiko Sawada, Keiichi Kubota, Syouhei Fuchinoue, Satoshi Teraoka, Akira Shimizu.   

Abstract

BACKGROUND: Chronic allograft nephropathy (CAN) remains the most important cause of late renal graft loss. However, the mechanism for graft dysfunction and the process of the development of CAN are not well understood. This study examined the role of microvascular injury in the development of CAN.
METHODS: We studied renal biopsies obtained from grafts with CAN (N= 79) and pretransplant control kidneys (N= 20). Microvascular injury was examined morphologically, and was correlated with interstitial fibrosis, glomerular sclerosis, graft function, and the severity of CAN. The humoral and cellular immunity involved in CAN were examined by C4d, CD3, and TIA-1 staining.
RESULTS: In all the cases of CAN, microvascular injury was evident with or without CD3-positive T cells, TIA-1-positive cytotoxic cells, and/or C4d+ complement deposition. Irrespective of chronic rejection (N= 14), C4d+ chronic humoral rejection (N= 6), or other CAN, the development process of CAN was characterized by injury and progressive loss of identifiable peritubular capillaries (PTCs) accompanied with the development of interstitial fibrosis. Injured PTCs were characterized morphologically by the process of angioregression with the presence of apoptotic cells, lamination of the basement membrane, and loss of PTCs. The low number of PTCs correlated significantly with the severity of CAN (r=-0.74, P < 0.001), the development of interstitial fibrosis (r=-0.75, P < 0.001), graft dysfunction (r=-0.69, P < 0.001), and also correlated weakly with proteinuria (r=-0.45, P < 0.05). In the glomeruli, capillary loss significantly correlated with the degree of glomerular sclerosis (r=-0.66, P < 0.001) and proteinuria (r=-0.65, P < 0.001), but did not correlate with the severity of CAN (r=-0.24, P > 0.05) or graft dysfunction (r=-0.32, P > 0.05).
CONCLUSION: CAN was characterized by progressive injury to the renal microvasculature and the development of renal scarring. In particular, injury, angioregression and progressive loss of the PTC network strongly contributed to the development of interstitial fibrosis and graft dysfunction in CAN, and might play a crucial role in the development of CAN.

Entities:  

Mesh:

Year:  2005        PMID: 15610258     DOI: 10.1111/j.1523-1755.2005.00085.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

1.  Early loss of peritubular capillaries after kidney transplantation.

Authors:  Floortje M E G Steegh; Marielle A C J Gelens; Fred H M Nieman; Johannes P van Hooff; Jack P M Cleutjens; Robert Jan van Suylen; Mat J A P Daemen; Ernst L W van Heurn; Maarten H L Christiaans; Carine J Peutz-Kootstra
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

Review 2.  Chronic alloantibody mediated rejection.

Authors:  R Neal Smith; Robert B Colvin
Journal:  Semin Immunol       Date:  2011-11-02       Impact factor: 11.130

3.  Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.

Authors:  Roel Bijkerk; Coen van Solingen; Hetty C de Boer; Pieter van der Pol; Meriem Khairoun; Ruben G de Bruin; Annemarie M van Oeveren-Rietdijk; Ellen Lievers; Nicole Schlagwein; Danielle J van Gijlswijk; Marko K Roeten; Zeinab Neshati; Antoine A F de Vries; Mark Rodijk; Karin Pike-Overzet; Yascha W van den Berg; Eric P van der Veer; Henri H Versteeg; Marlies E J Reinders; Frank J T Staal; Cees van Kooten; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

Review 4.  The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.

Authors:  Héloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2016-10-17       Impact factor: 10.121

5.  Vascular endothelial cadherin modulates renal interstitial fibrosis.

Authors:  Ikuyo Yamaguchi; Bie Nga Tchao; Megan L Burger; Muneharu Yamada; Toshitake Hyodo; Costanza Giampietro; Allison A Eddy
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

Review 6.  Regenerating a kidney in a lymph node.

Authors:  Maria Giovanna Francipane; Eric Lagasse
Journal:  Pediatr Nephrol       Date:  2015-12-21       Impact factor: 3.714

Review 7.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

Review 8.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

9.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

10.  H-Y antibody development associates with acute rejection in female patients with male kidney transplants.

Authors:  Jane C Tan; Persis P Wadia; Marc Coram; F Carl Grumet; Neeraja Kambham; Katherine Miller; Shalini Pereira; Tamara Vayntrub; David B Miklos
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.